SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-15-162396
Filing Date
2015-04-30
Accepted
2015-04-30 16:54:00
Documents
5
Effectiveness Date
2015-04-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS d918887ddefa14a.htm DEFA14A 17739
2 GRAPHIC g9188871.jpg GRAPHIC 60466
3 GRAPHIC g9188872.jpg GRAPHIC 93850
4 GRAPHIC g9188873.jpg GRAPHIC 27266
5 GRAPHIC g9188874.jpg GRAPHIC 15716
  Complete submission text file 0001193125-15-162396.txt   291149
Mailing Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025 650-272-6269
Avalanche Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36579 | Film No.: 15819732
SIC: 2836 Biological Products, (No Diagnostic Substances)